Skip to main content

Table 4 Self-reported complaints post day 1 of treatment ‘adverse events’

From: Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine

Adverse effects

AL only

AL + primaquine day 1

AL + primaquine day 3

Participants with adverse events (%)

9 (34.6)

6 (23.1)

11 (42.3)

Number of adverse events*

10

8

13

Cough

4

3

2

Skin rush

1

0

0

Headache

2

1

4

Dizziness

1

0

0

Abdominal discomfort/pain

2

2

1

Loss of appetite

0

1

2

Vomiting

0

0

1

Diarrhoea

0

0

1

Otitis media

0

1

0

Conjunctivitis

0

0

1

Painful micturition

0

0

1

  1. AL artemether–lumefantrine
  2. *44% of adverse events were reported on day 2 of follow up